Recombinant expression and in Vitro characterisation of active huwentoxin-IV

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sermadiras, Isabelle ^a   Revell, Jefferson ^a   Linley, John E ^b   Sandercock, Alan ^a   Ravn, Peter ^a  

^a MEDIMMUNE   (United States)

^b MEDIMMUNE LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CARBOXYLIC ACID; GLYCINE; HUWENTOXIN IV; HYBRID PROTEIN; NEUROTOXIN; SODIUM CHANNEL NAV1.7; SUMO PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; ESCHERICHIA COLI; IC 50; IN VITRO STUDY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE EXPRESSION; GLYCINE; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPIDER VENOMS;

EID: 84891919904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083202     Document Type: Article

References (40)

1. Peng K, Shu Q, Liu Z, Liang S (2002) Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin (TTX)-sensitive sodium channel antagonist from Chinese bird spider Selenocosmia huwena. J Biol Chem 277: 47564-47571. doi:10.1074/jbc.M204063200. PubMed: 12228241. (Pubitemid 36159276)
2. Klint JK, Senff S, Rupasinghe DB, Er SY, Herzig V et al. (2012) Spidervenom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads. Toxicon 60: 478-491. Doi:10.1016/j. toxicon.2012.04.337. Pubmed: 22543187.
3. Xiao Y, Bingham J-P, Zhu W, Moczydlowski E, Liang S et al. (2008) Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration. J Biol Chem 283: 27300-27313. doi:10.1074/jbc.M708447200. PubMed: 18628201.
4. Cummins TR, Dib-Hajj SD, Waxman SG (2004) Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 24: 8232-8236. doi:10.1523/JNEUROSCI. 2695-04.2004. PubMed: 15385606. (Pubitemid 39280802)
5. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E et al. (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444: 894-898. doi:10.1038/nature05413. PubMed: 17167479. (Pubitemid 46024997)
6. Craik DJ, Daly NL, Waine C (2001) The cystine knot motif in toxins and implications for drug design. Toxicon 39: 43-60. doi:10.1016/S0041-0101(00) 00160-4. PubMed: 10936622.
7. Xiao Y, Luo X, Kuang F, Deng M, Wang M et al. (2008) Synthesis and characterization of huwentoxin-IV, a neurotoxin inhibiting central neuronal sodium channels. Toxicon 51: 230-239. doi:10.1016/j.toxicon.2007.09.008. PubMed: 18054060.
8. Revell JD, Lund P-E, Linley JE, Metcalfe J, Burmeister N et al. (2013) Potency optimization of Huwentoxin-IV on hNav1.7: A neurotoxin TTXS sodium-channel antagonist from the venom of the Chinese birdeating spider Selenocosmia huwena. Peptides 44C: 40-46. PubMed: 23523779.
9. Che N, Wang L, Gao Y, An C (2009) Soluble expression and one-step purification of a neurotoxin Huwentoxin-I in Escherichia coli. Protein Expr Purif 65: 154-159. doi:10.1016/j.pep.2009.02.002. PubMed: 19217942.
10. Meng E, Cai T-F, Li W-Y, Zhang H, Liu Y-B et al. (2011) Functional expression of spider neurotoxic peptide huwentoxin-I in E. coli. PLOS ONE 6: e21608. doi:10.1371/journal.pone.0021608. PubMed: 21731778.
11. Pluzhnikov K, Vassilevski A, Korolkova Y, Fisyunov A, Iegorova O et al. (2007) omega-Lsp-IA, a novel modulator of P-type Ca2+ channels. Toxicon 50: 993-1004. doi:10.1016/j.toxicon.2007.07.004. PubMed: 17888477. (Pubitemid 350026579)
12. Smith JJ, Cummins TR, Alphy S, Blumenthal KM (2007) Molecular interactions of the gating modifier toxin ProTx-II with NaV 1.5: implied existence of a novel toxin binding site coupled to activation. J Biol Chem 282: 12687-12697. doi:10.1074/jbc.M610462200. PubMed: 17339321. (Pubitemid 47100615)
13. Singer HM, Erhardt M, Steiner AM, Zhang M-M, Yoshikami D et al. (2012) Selective purification of recombinant neuroactive peptides using the flagellar type III secretion system. mBio 3: 1-9. doi:10.3391/mbi. 2012.3.1.01. PubMed: 22647788.
14. Li M, Li LY, Wu X, Liang SP (2000) Cloning and functional expression of a synthetic gene encoding huwentoxin-I, a neurotoxin from the Chinese bird spider (Selenocosmia huwena). Toxicon 38: 153-162. doi: 10.1016/S0041-0101(99)00123-3. PubMed: 10665797. (Pubitemid 29512188)
15. Cao Z, Xiao F, Peng F, Jiang D, Mao X et al. (2003) Expression, purification and functional characterization of a recombinant scorpion venom peptide BmTXKβ. Peptides 24: 187-192. doi:10.1016/S0196-9781(03)00025-1. PubMed: 12668201. (Pubitemid 36369337)
16. Schmoldt H-U, Wentzel A, Becker S, Kolmar H (2005) A fusion protein system for the recombinant production of short disulfide bond rich cystine knot peptides using barnase as a purification handle. Protein Expr Purif 39: 82-89. doi:10.1016/j.pep.2004.09.016. PubMed: 15596363. (Pubitemid 39645385)
17. Ji W, Zhang X, Hu H, Chen J, Gao Y et al. (2005) Expression and purification of Huwentoxin-I in baculovirus system. Protein Expr Purif 41: 454-458. doi:10.1016/j.pep.2005.02.012. PubMed: 15866735. (Pubitemid 40607793)
18. Escoubas P, Bernard C, Lambeau G, Lazdunski M, Darbon H (2003) Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels. Protein Sci 12: 1332-1343. doi:10.1110/ps.0307003. PubMed: 12824480. (Pubitemid 36759338)
19. Berkmen M, Boyd D, Beckwith J (2005) The nonconsecutive disulfide bond of Escherichia coli phytase (AppA) renders it dependent on the protein-disulfide isomerase, DsbC. J Biol Chem 280: 11387-11394. doi:10.1074/jbc.M411774200. PubMed: 15642731. (Pubitemid 40418447)
20. Berkmen M (2012) Production of disulfide-bonded proteins in Escherichia coli. Protein Expr Purif 82: 240-251. doi:10.1016/j.pep. 2011.10.009. PubMed: 22085722.
21. Kurokawa Y, Yanagi H, Yura T (2001) Overproduction of bacterial protein disulfide isomerase (DsbC) and its modulator (DsbD) markedly enhances periplasmic production of human nerve growth factor in Escherichia coli. J Biol Chem 276: 14393-14399. PubMed: 11279016.
22. Qiu J, Swartz JR, Georgiou G, Qiu JI (1998) Expression of Active Human Tissue-Type Plasminogen Activator in Escherichia coli. Appl Environ Microbiol 64: 4891-4896. PubMed: 9835579. (Pubitemid 28557856)
23. Nozach H, Fruchart-Gaillard C, Fenaille F, Beau F, Ramos OH et al. (2013) High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfiderich proteins in E. coli. Microb Cell Fact 12: 37. doi: 10.1186/1475-2859-12-37. PubMed: 23607455.
24. Bessette PH, Aslund F, Beckwith J, Georgiou G (1999) Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci U S A 96: 13703-13708. doi:10.1073/pnas.96.24.13703. PubMed: 10570136.
25. Tait AR, Straus SK (2011) Overexpression and purification of U24 from human herpesvirus type-6 in E. coli: unconventional use of oxidizing environments with a maltose binding protein-hexahistine dual tag to enhance membrane protein yield. Microb Cell Fact 10: 51. doi: 10.1186/1475-2859-10-51. PubMed: 21714924.
26. Lobstein J, Emrich Ca, Jeans C, Faulkner M, Riggs P et al. (2012) SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm. Microb Cell Fact 11: 56. doi:10.1186/1475-2859-11-56. PubMed: 22569138.
27. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD et al. (2004) SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics 5: 75- 86. doi:10.1002/cfg.362. PubMed: 15263846.
28. Marblestone JG, Edavettal SC, Lim Y, Lim P, Zuo X et al. (2006) Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. Protein Sci 15: 182-189. doi:10.1110/ps.051812706. PubMed: 16322573. (Pubitemid 43004245)
29. Bosse-Doenecke E, Weininger U, Gopalswamy M, Balbach J, Knudsen SM et al. (2008) High yield production of recombinant native and modified peptides exemplified by ligands for G-protein coupled receptors. Protein Expr Purif 58: 114-121. doi:10.1016/j.pep. 2007.10.012. PubMed: 18248821.
30. Satakarni M, Curtis R (2011) Production of recombinant peptides as fusions with SUMO. Protein Expr Purif 78: 113-119. doi:10.1016/j.pep. 2011.04.015. PubMed: 21586326.
31. Prigge ST (1997) Amidation of Bioactive Peptides: The Structure of Peptidylglycine -Hydroxylating Monooxygenase. Science 278: 1300- 1305. doi:10.1126/science.278.5341.1300. PubMed: 9360928. (Pubitemid 27495743)
32. Mehta NM, Carpenter SE, Consalvo AP (2009) C-Terminal a- Amidation. In: G Walsh. Post-translational Modification of Protein Biopharmaceuticals. Wiley-VCH. pp. 253-276.
33. Kim K, Seong B (2001) Peptide amidation: Production of peptide hormones in vivo and in vitro. Biotechnol and Bioprocess Eng 6: 244-251. doi:10.1007/BF02931985. (Pubitemid 33811609)
34. Ray MV, Meenan CP, Consalvo AP (2002) Production of salmon calcitonin by direct expression of a glycine-extended precursor in Escherichia coli. Protein Expr Purif 26: 249-259. doi:10.1016/S1046-5928(02)00523-5. PubMed: 12406679. (Pubitemid 35326543)
35. Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2: 790-802. doi:10.1038/nrd1197. PubMed: 14526382. (Pubitemid 37361811)
36. Diao J, Lin Y, Tang J, Liang S (2003) cDNA sequence analysis of seven peptide toxins from the spider Selenocosmia huwena. Toxicon 42: 715-723. doi:10.1016/j.toxicon.2003.08.007. PubMed: 14757201. (Pubitemid 38125029)
37. Zhang Z-Z, Yang S-S, Dou H, Mao J-F, Li K-S (2004) Expression, purification, and C-terminal amidation of recombinant human glucagonlike peptide-1. Protein Expr Purif 36: 292-299. doi:10.1016/j.pep.2004.03.014. PubMed: 15249052. (Pubitemid 38893166)
38. Chakraborty C, Nandi S, Sinha S (2004) Overexpression, purification and characterization of recombinant salmon calcitonin, a therapeutic protein, in Streptomyces avermitilis. Protein Pept Lett 11: 165-173. doi: 10.2174/0929866043478266. PubMed: 15078205. (Pubitemid 38504066)
39. Qi X, Jiang R, Yao C, Zhang R, Li Y (2008) Expression, purification, and characterization of C-terminal amidated glucagon in Streptomyces lividans. J Microbiol Biotechnol 18: 1076-1080. PubMed: 18600050.
40. Cottingham IR, Millar A, Emslie E, Colman A, Schnieke AE, et al. (2001) A method for the amidation of recombinant peptides expressed as intein fusion proteins in Escherichia coli. Nat Biotechnol 19: 974-977. (Pubitemid 32947579)